Rapid and durable responses with the SYK/JAK inhibitor cerdulatinib in a phase 2 study in relapsed/refractory follicular lymphoma-alone or in combination with rituximab Meeting Abstract
| Authors: | Smith, S. D.; Munoz, J.; Stevens, D.; Smith, S. M.; Feldman, T. A.; Ye, J. C.; de Vos, S.; Hess, B. T.; Miller, C. B.; Khatcheressian, J. L.; Birrell, M. R.; Leeds, J. M.; Coffey, G. P.; Conley, P. B.; Michelson, G. C.; Curnutte, J. T.; Hamlin, P. A. |
| Abstract Title: | Rapid and durable responses with the SYK/JAK inhibitor cerdulatinib in a phase 2 study in relapsed/refractory follicular lymphoma-alone or in combination with rituximab |
| Meeting Title: | 61st Annual Meeting and Exposition of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 134 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Dec 7-10 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2019-11-13 |
| Language: | English |
| ACCESSION: | WOS:000577164602004 |
| DOI: | 10.1182/blood-2019-124231 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 3981 -- Source: Wos |
